Shareable Research Card

NOVAGANT CORP Cash and Cash Equivalents, Period Increase (Decrease)

This metric view shows NOVAGANT CORP cash and cash equivalents, period increase (decrease) history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2021
Latest reported value
$3,987

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Mar 2022
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2021.
  • Latest reported value on this page: $3,987.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Cash and Cash Equivalents, Period Increase (Decrease)

New fact period available

Latest reported cash and cash equivalents, period increase (decrease): $3,987. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Mar 2022

Page type

Metric history

Latest period

2021

SEC-backed company facts were refreshed from filings filed on 14 Feb 2024.

Benchmark Context

How Cash and Cash Equivalents, Period Increase (Decrease) compares with peers

NOVAGANT CORP is outside the visible top 120 companies for cash and cash equivalents, period increase (decrease) in the current sample.

Compared with

Compared with 120 companies reporting cash and cash equivalents, period increase (decrease) in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Cash and Cash Equivalents, Period Increase (Decrease) is down about 52% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2022.
  • Nearby companies in this sample: AT&T INC. and AbbVie Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

NOVAGANT CORP: Cash and Cash Equivalents, Period Increase (Decrease)

Latest period: 2021. Period end: 31 Mar 2022. Units: USD. Frequency: annual.

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

What this metric tells you

  • Shows reported cash and cash equivalents, period increase (decrease) over 31 Mar 2021 - 31 Mar 2022.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 2 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Cash and Cash Equivalents, Period Increase (Decrease) levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
USD
History range
31 Mar 2021 - 31 Mar 2022
Facts on this page
2
How to read it 1 detail
Metric definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of...
Open details
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Cash and Cash Equivalents, Period Increase (Decrease), Annual (USD)
Cash and Cash Equivalents, Period Increase (Decrease), YoY Annual Change (%)

NOVAGANT CORP Annual Cash and Cash Equivalents, Period Increase (Decrease) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $3,987 -$4,290 -52% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2022 2022 FY
2020 $8,277* 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .